Optimized culture conditions for tissue explants of uterine leiomyoma by Fiebitz, A. et al.
 Clin. Lab. 11+12/2012 1153
Clin. Lab. 2012;58:1153-1164 
©Copyright 
ORIGINAL ARTICLE 
 
 
 
Optimized Culture Conditions for Tissue Explants of  
Uterine Leiomyoma 
 
A. FIEBITZ 1, M. FRITSCH 3, U. REICHELT 2, C. RUESTER 1, V. CHIANTERA 1,  
G. F. VERCELLINO 1, A. DARWISH 1, A. SCHNEIDER 1, S. MECHSNER 1 
 
1 Department of Gynaecology, Charité Hospital Campus Benjamin Franklin, Berlin, Germany 
2 Department of Pathology, Charité Hospital Campus Benjamin Franklin, Berlin, Germany 
3 Bayer Pharma AG Bayer HealthCare Pharmaceuticals, Berlin, Germany 
 
 
 
 
SUMMARY 
 
Background: Uterine leiomyomas are the most common benign tumours in women, which arise from smooth mus-
cle cells of the uterine myometrium and usually are multicentric. In spite of their frequency pathogenesis is widely 
unknown, mainly due to the absence of a suitable model system. We describe the systematic optimization of cul-
turing leiomyoma tissue explants in an economical and effective ex vivo system.  
Methods: Different concentrations of oxygen, different media, sera, hormones, and growth factor supplements 
were tested. Immunohistochemical stainings with antibodies against hormone receptors as well as specifying pro-
liferation and apoptotic indices and real-time PCR were performed.  
Results: Main parameters for culturing myoma tissue explants were tested for finding an optimal protocol. Stan-
dard medium D-MEM-F12 in combination with the use of horse serum in a reduced concentration of 1% turned 
out to be optimal for these tissue cultures as well as the addition of estradiol and epidermal growth factor EGF to 
media. Reduced oxygen content in the incubator air showed no positive effect.  
Conclusions: For culturing tissue explants of uterine leiomyoma several conditions were optimized. The estab-
lished tissue culture model allows examining the effects of known and potential therapeutic substances and the in-
fluence of immune competent cells in the process of tumour formation to find new targets for medical treatment. 
(Clin. Lab. 2012;58:1153-1164. DOI: 10.7754/Clin.Lab.2012.111117)  
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INTRODUCTION 
 
Uterine myomas are mostly multiple tumours arising as 
monoclonals from smooth muscle cells. The lifelong 
risk of getting myomas is about 70%, and 10 to 25% of 
patients have symptoms such as pain, infertility, or 
bleeding problems, which seem to correlate with size, 
quantity and locations of the tumours [1].  
Myomas are hormone dependant, but there are also oth-
er modulators of genesis and growth such as different 
tumour suppressors [2], locale cytokines and growth 
factors [3,4], and, in addition, macrophages, T-cells, 
and mastocytes were found to be increased in myomas 
[5]. Cell form and cytoskeleton are modified as well as 
amount, structure, and compounds of the extracellular 
matrix [6,7].  
Studies with microarrays or miRNA detected a number 
of genes differently expressed in myomas and myome-
trium, mostly associated with cell cycle regulation, dif-
ferentiation, apoptosis, inflammation or the extracellular 
matrix. Other studies are based on animal models. Lead 
in this field is the so called “EKER rat”, frequently de-
veloping myomas and other tumours due to a mutation 
in the TSC2 tumour suppressor gene. Besides the disad-
vantages such as high costs and effort, it should be kept 
in mind that the histology of the tissue is occasional sar-
coma-like [8] and that not only reproductive biology but 
also pathways of human and rat are sometimes mani-
festly different. Thus, especially for detecting new tar-
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gets for medicament therapy of uterine myomas, animal 
models are limited. For example, the two hormone-
based drugs Raloxifen and Tamoxifen showed very pro-
mising results in animal models [9,10] but were very 
disappointing in clinical tests with premenstrual women 
[11,12]. Thus human model systems are not only desir-
able but necessary, and the lack of a suitable model is 
one of the main reasons for the nescience about the 
pathology of uterine myomas. Freshly extracted human 
tissue from hysterectomies is often used for analysing 
expression changes (see above) between myomas and 
myometrium, but this model is only of limited applica-
tion for functional studies. Thus some scientists use cul-
tivated cells from myomas; however to use them as a 
cell line they have to be immortalised by HPV-16 genes 
or telomerase-reverse-transcriptase [13,14] due to 
scanty growth and early senescence under culture con-
ditions [15,16], which may change phenotype of myo-
ma cells [17]. Another barrier to using cell cultures in 
myoma studies is the problem of fast cell dedifferentia-
tion [14,18,19]. Within hours after beginning of cul-
turing, m-RNA transcripts of ER and PR were de-
creased, independent of adding estrogens and/or proges-
terone. Gene expression between normal and tumour 
tissue in some cases is more similar than between tu-
mour tissue and related culture [20]. Last but not least, 
the model system of cell culture could not consider cell 
interactions, autocrine and paracrine factors or the ex-
tracellular matrix (ECM), which is an important aspect 
in myoma (see above). The only useful cell line of uter-
ine myoma is ELT3 from the EKER rat and thus from 
non-human origin. Even xenograft studies with labora-
tory animals [8,21] could not completely fill the gap of 
the need of a broad based model without involvement of 
a non-human, non-menstruating organism. Thus there is 
a special need for an alternative model in the field of 
uterine leiomyoma. The cultivation of tissue explants 
offers such an alternative. This ex vivo model does not 
need any dissimilar organism, is low in cost and mate-
rial effort, and takes all components of the tissue as-
sembly including cell interactions and ECM compo-
nents into account. This makes the cultivating of ex-
plants of this tumour tissue suitable for all fundamental 
questions as well as for studying new therapeutical ap-
plications. Here we present a suitable protocol for cul-
turing tissue explants of uterine myoma with low cost 
and effort.  
 
 
MATERIALS AND METHODS 
 
Tissue Culture 
The tissue for culturing came from myoma extracting 
surgeries, which took place at the Charité Campus Ben-
jamin Franklin Hospital between October 2008 and 
February 2011, the decision of the ethics committee 
(EA4/117/09) is on hand. Directly after extraction, tis-
sue is placed into cooled HANKS buffer (PAA). For 
cultivating, the material was cut into small, uniform 
slices using a Vibratom (Leica VT 1200S). This precise 
cutting machine with vibrating blade enables specified 
parameters providing comparable slices of 500 µm. 
Best results were achieved with an amplitude of       
2.00 mm and frequency of 0.10 mm/s.  
Embedding the tissue blocks in 4% agarose was tested, 
but was not beneficial because of the increased risk that 
the agarose block with the tissue separates from the 
holder. Beside this, the first aim is to reduce the time 
between myoma extraction and culturing in the incubi-
tor as much as possible to get the best results in cell fit-
ness.  
Tissue slices were placed in 6-well plates for cell cul-
ture (TPP®) in combination with a metal grid set in each 
well (“grid-well”). Since the availability and composi-
tion of gas are important parameters for cultivation of 
other tissues [22,23], we compared standard 6-well 
plates (TPP®) for cell culture (with and without the use 
of a metal grid as holder for the tissue pieces in each 
well) with two other cell culture systems. One was the 
LumoxTM-cell culture system (in Vitro Systems), where 
the bottom is made of a special membrane und thus al-
lows an increased gas exchange.  
The other one was a “center well” culture dish (BD), 
with the additition of a “Nucleopore Track-Etch” mem-
brane (Whatman® Schleicher & Schuell). Tissue pieces 
were set on top of the membrane and thus had contact 
with the gas phase above and contact with the media 
below through the membrane. Rolling culture systems 
were not tested. They are mainly suitable for tissues 
with high requirement of oxygen, which is not the case 
for myoma. The LumoxTM-cell culture system gave 
good results and is easy to handle; however, the much 
lower cost of the 6-well plates in combination with met-
al grids (named as “grid-well”), which were in same 
quality range, were chosen for further culturing. For 
economic use of the LumoxTM system, plates can be 
combined with flexi PERM discs (In Vitro) which are 
small plastic subdivisions for use in cell culture.  
Culture media contained a final concentration of 1% 
antibiotic (penicillin/streptomycin, Biochrom), 1% anti-
mycoticum (amphotericin B, PPA), and 1% L-Glutamin 
(Biochrom). To visualise the proliferation status of the 
tissue slices after culturing, BrdU (Bromodeoxyuridine, 
Sigma- Aldrich®) was added to a final concentration of 
10 µmol/L. Sera and other supplements differ in some 
of the tests (see results), if not noted otherwise, horse 
serum (Biochrom) at a final concentration of 1% as well 
as estradiol E2 (Sigma-Aldrich®) at a final concentra-
tion of 10-8 M were added to D-MEM/F12 without phe-
nol red (Gibco®) as standard medium. The addition of 
ITS (insulin transferrin selenium, Cellgro® Mediatech) 
showed no clear advantage in tests and was thus not 
used routinely (data not shown).  
If not noted otherwise, culturing was done for 48 hours. 
Tissues were then fixed in 3.7% paraformaldehyde for 
embedding in paraffin and used in IHC or shock frozen 
in liquid nitrogen and stored at -80°C for quantitative 
analysis via real-time PCR. As control for every experi-
CULTURING UTERINE LEIOMYOMA 
Clin. Lab. 11+12/2012 1155
ment a cut slide without culturing was stored in para-
formaldehyde or shock frozen.  
 
Immunhistochemical detection of selected markers 
To detect different markers in slices of cultured myoma 
tissue, they were fixed in 3.7% paraformaldehyde for a 
minimum of 24 hours directly after culturing and then 
embedded in paraffin. These tissue blocks were cut into 
2 µm slices and placed on glass slides. Before immun-
histochemistry, slides were baked for 2 to 16 hours at 
60°C and then deparaffinised in a descending alcohol 
series. Tissue pieces were inactivated in the manner ap-
propriate for every staining. Antibodies were diluted in 
antibody diluent (DAKO®) and blocking was done with 
a PBS/5% BSA solution. Biotin-based stainings were 
additionally blocked with Avidin and Biotin solutions 
(DAKO®); DAB-based stainings were blocked against 
endogen peroxidase (peroxidase blocking solution, DA 
KO®).  
In most cases, inactivation was done via heat in a 
steamer for 40 minutes followed by cooling in ice; the 
exceptions were BrdU and apoptosis detection (see be-
low). To stain estrogen receptor (ER), “Target 9” (DA 
KO®) was used as buffer during heat inactivation; all 
others were placed in citrate buffer in this step. The col-
ouring system was Fuchsin Substrate-Chromogen (DA 
KO®) and counterstaining was done with Mayers Hä-
malaun solution (Merck). After this, tissues were coated 
with Kaiser’s glycerine gelatine (Merck) and covered 
with a glass coverslip. 
Antibodies against the hormone receptors were mono-
clonal mouse anti-human ER alpha (DAKO®) and mo-
noclonal mouse anti-human progesterone receptor PR 
(DAKO®). Alpha smooth muscle actin was detected by 
monoclonal mouse anti human alpha smooth muscle ac-
tin (DAKO®). Markers for the detection of the extracel-
lular matrix (ECM) were monoclonal mouse anti der-
matopontin (DPT) from Abnova and monoclonal mouse 
anti versican from Santa Cruz. Proliferation of the tissue 
slices were detected with monoclonal mouse anti-BrdU 
(DAKO®) and monoclonal mouse anti Ki-67 clone 
MIB-I (DAKO®). Secondary antibody was Biotin-SP 
conjugated Affini Pure Mouse Anti-Rabbit IgG (Jack-
son Immuno Research) and “Streptavidin-AP conju-
gated” from Roche. 
Proliferation was carried out in two different ways. On 
the one hand, an antibody against BrdU added to the 
media in the beginning of tissue culturing (see above) 
was used, on the other hand, IHC was done with the Ki-
67 analogue MIB-I antibody. MIB-I staining was done 
as described for the detection of BrdU; deparaffinzied 
slices were demasked with HCl (10 minute incubation 
in 1 N HCl on ice followed by 30 minute incubation in 
2 N HCl at 37°C), neutralised with 0.1 M borate buffer 
and water. The colouring system used here EnVision + 
System HRP (DAB) (DAKO®), and counterstaining 
was done with Mayers Hämalaun solution (Merck). Af-
ter dehydration in an ascending alcohol series, samples 
were coated with Eukitt® quick-hardening mounting 
medium (Fluka BioChemika) and covered with a glass 
coverslip. For detection of apoptotic cells, the Apop 
Tag®plus kit from Chemicon® was used. After descend-
ing alcohol series, tissue slices were demasked using the 
enzyme proteinkinase K (ExpressArt®). Colouring sys-
tem, counterstaining, and mounting of the slides were to 
the same as for the BrdU staining.  
Evaluation and documentation for all stainings were 
done via light microscope (Zeiss, Axiophot) and a digi-
tal camera (Canon, Powershot G5).  
 
Analysis of mRNA via real-time PCR 
For quantitative analysis, the cultured tissues were 
shock frozen in liquid nitrogen and stored at -80°C (see 
above). RNA extraction of myomas proved to be very 
difficult and therefore different protocols were tested. In 
conclusion, extraction via the trizol-chloroform-method 
turned out to be best; however, it was very important 
that tissues were kept frozen continuously (cooled with 
liquid nitrogen and dry ice) in the first step to shield 
RNA from degradation. In this step, tissue was crushed 
with a mortar until it was a fine powder, and then it was 
mixed with trizol. After this, in the trizol, the tissue was 
allowed to thaw. After separation with chloroform, pre-
cipitation, and washing steps, the quality of the RNA 
was controlled by nano-drop and used for c-DNA syn-
thesis via SuperScript® II reverse transcriptase, random 
primers (InvitrogenTM), and RNasin® ribonuclease inhi-
bitors (Promega).  
For real-time PCR, TaqMan® universal PCR master mix 
(Applied Biosystems) was used. Primers were PR As-
say ID Hs01556702_m1*, ER Assay ID Hs001748 
60_m1*, and GAPDH for normalisation (Assay ID 
Hs99999905_m1) from Applied BiosystemsTM. Mea-
surement was done using the software “Chromo 4 Four-
Colour Real-Time Systems” (BioRad).  
 
Statistical Analysis 
All tests were done with a minimum of three biological 
replicates. Signals of the stainings were detected via 
light microscope. For proliferation and apoptotic in-
dices, a 4-step scale was used (0 = no positive cell, 3 = 
high number of positive cells), results of the prolifer-
ation stainings (BrdU and MIB-I) were merged. In all 
other cases, signals were classified in a percentage 
range. Results of the real time PRC were analysed using 
calculating delta c(t). Statistical analyses in all tests 
were made using GraphPad Prism 4 (GraphPad Soft-
ware, USA). Statistical significances were determined 
accordingly by one-way ANOVA (Kruskal-Wallis test), 
Mann-Whitney, and paired t-test where p < 0.05 was 
considered statistically significant. 
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RESULTS 
 
Suitable media for culturing myoma tissue 
An important factor in finding optimal culture condi-
tions is the choice of media. To find a suitable medium 
for culturing myoma tissue, standard media D-
MEM/F12 (InvitrogenTM) and two special media for 
smooth muscle cells (MCDB-131 from c.c.pro GMbH 
and Smooth Muscle Cell Growth Medium from Promo 
Cell) were compared. All media were used in variants 
without phenol red since it has been suggested that this 
supplement could affect the growth of ER-dependent 
tissues [24]. Media were supplemented with antibiotics, 
antimycotics, L-glutamine, and serum as described 
above.  
Comparison of the tested media regarding the prolifer-
ation index showed D-MEM/F12 to be almost similar to 
MCDB-131; smooth muscle cell growth media (SMC) 
showed bad results in all tests (Figure 1a). Similar re-
sults were found regarding the apoptotic index (1b), es-
trogen receptor, and progesterone receptor (data not 
shown). Since the results of D-MEM/F12 were signifi-
cantly better compared to SMC and only minimal dif-
ferences were seen between D-MEM/F12 and MCDB-
131 in all tests (no significances), the lower-priced 
media, D-MEM/F12, was chosen as the standard for all 
further experiments with myoma tissue cultures.  
 
Optimal serum for culturing myoma tissue 
The type of serum and its concentration could have a 
big influence on the culture quality. To determine the 
best composition of the nutrient solution for culturing 
uterine myoma, different sera and alternatives to serum 
as well as different concentrations of the sera were 
tested. Mostly we used common fetal calf serum (FCS), 
horse serum (HS), and Ultroser®-G (CytoGen) as serum 
replacement, and compared these with tissue slices cul-
tured in medium without any serum or serum replace-
ment. Ultroser®-G was used at a final concentration of 
1%, and FCS and HS were tested at concentrations of 
5% and 1%, respectively.  
The highest proliferation index was found using FCS at 
a final concentration of 1%, but differences were not 
significant (Figure 2a). In contrast, apoptosis was better 
than the other tested approaches using HS at a final con-
centration of 1% with or without Ultroser®-G, but also 
here differences were not significant (Figure 2b). Detec-
tion of ER and PR in myoma tissues after culturing (im-
munhistochemistry as well as real time PCR of the hor-
mone receptor’s mRNA) showed no unique results for 
the different sera and no significant differences (data 
not shown).  
All together, a final serum concentration of 1% seems to 
be better than 5%. FCS seems to increase the prolifera-
tion index more than HS, but on the other hand, using 
HS lowered the apoptosis index compared to FCS. HS 
therefore was chosen as standard. serum replacement as 
Ultroser®-G showed no strong advantage (alone or in 
combination with HS), and because of higher costs it 
was not used for further tests. 
 
Addition of hormones to the medium 
Because of the known hormone dependence of uterine 
leiomyomata, we tested the addition of estrogens (estra-
diol E2) and progesterone (P) to the culture medium to 
show their effects on cultured slices of myoma tissue. 
Hormones were added together and individually at dif-
ferent concentrations from 10-6 M to 10-10 M and in 
comparison with tissue slices cultured in medium with-
out addition of any external hormone.  
 
Addition of E2 alone 
Adding estradiol alone seemed to give the best results 
with a final concentration of 10-8 M with respect to 
apoptosis, but most of the differences were not signifi-
cant (Figure 3b). No significant differences with respect 
to the proliferation index were found (Figure 3a). 
 
Addition of P alone 
Adding progesterone alone seemed to give the best pro-
liferation and apoptotic indices using a final concen-
tration of 10-6 M, but these differences were not signifi-
cant (data not shown). 
 
Addition of E2 and P together  
When progesterone was combined with 10-8 M estradiol 
(final concentration) as medium supplement, results 
were analogue to the addition of progesterone alone and 
showed no significant differences (data not shown). 
Neither estradiol nor progesterone in combination or in-
dividually have detectable positive effects on the hor-
mone receptor proteins ER and PR (data not shown). 
All together, the addition of 10-8 M estradiol seemed to 
be best in the test and showed a tendency toward a posi-
tive effect on culturing uterine myoma with regard to 
apoptosis. It showed an advantage versus the addition of 
progesterone and also when a combination of both hor-
mones was used. 
 
Addition of EGF to the medium 
EGF is one of the growth factors which seem to have an 
important influence on the growth of myoma, thus we 
tested the effect of EGF on cultured tissue explants of 
this tumour. It was added to the culture medium to final 
concentrations from 10-7 to 10-10 M. These tests were 
compared with slices of tissue cultured in medium con-
taining no external growth factor.  
The best apoptotic index was found using a final con-
centration of 10-7 M EGF (Figure 4a). The same con-
centration results in a higher amount of ER positive 
cells, but these differences were not significant (Figure 
4b). Neither higher nor lower concentrations of EGF 
seem to have a clear influence on the amount of PR pos-
itive cells (data not shown). Proliferation was very low 
in all tests and showed no significant difference when 
EGF was added, no matter what concentration (data not 
 
CULTURING UTERINE LEIOMYOMA 
Clin. Lab. 11+12/2012 1157
 
 
 
 
 
 
Figure 1. Comparison of different media (D-MEM/F-12, MCDB-131 and Smooth Muscle Cell Basal Medium (SMC)) for cul-
turing uterine myoma tissue by analysis of proliferation index (a) and apoptotic index (b). Proliferation index using D-
MEM/F12 was significantly higher than the proliferation index when SMC was used; no significant differences were found be-
tween D-MEM/F12 and MCDB-131 or between MCDB-131 and SMC. Apoptosis was significantly higher with the use of SMC 
compared to D-MEM/F12. *p < 0.05. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Comparison of different sera (fetal calf serum = FCS, horse serum = HS, and serum replacement Ultroser®-G at dif-
ferent final concentrations in media for culturing uterine myoma tissue by analysis of the proliferation index (a) and apoptotic 
index (b). Differences between the proliferation indices using the different sera and concentrations were not significant. Apo-
ptosis using HS 1% alone or in combination with Ultroser G 1% was lower than of all other tested serum combinations, but 
not significant. *p < 0.05. 
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Figure 3. Addition of Estradiol E2 at different final concentrations from 10-6 M to 10-10 M in comparison to media without ex-
ternal hormones in cultured uterine myoma tissue analysed by proliferation index (a), and apoptotic index (b). Apoptosis was 
lower when E2 was added to culturing medium at a final concentration of 10-8 M, *p < 0.05. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Addition of growth factor EGF at different final concentrations from 10-7 to 10-10 M in comparison to media without 
external growth factors in cultured uterine myoma tissue analysed by apoptotic index (a) and IHC of ER (b). By using EGF at 
a final concentration of 10-7 M, the apoptotic index was significantly lower than without the addition of this growth factor; dif-
ferences in IHC tests were not significant. *p < 0.05. 
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Figure 5. Myoma tissue explants cultured from 24 to 144 hours under normoxic vs. hypoxic conditions. Shown are the prolif-
eration index (a) and the apoptotic index (b). No significant difference was found between the two gassing conditions, neither 
for the proliferation index nor for the apoptotic index, *p < 0.05. 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Presence of hormone receptors ER (a) and PR (b) in cultured uterine myoma tissue with regard to dif-ferent culture 
durations (0 hours of culture matches native tissue). The content of ER positive cells was signifi-cantly lower after 72 hours 
compared to native tissue. The content of PR positive cells was already significantly lower after 48 hours compared to native 
tissue. *p < 0.05. 
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shown). Taken together, the growth factor EGF seems 
to have a certain but low influence on cultured tissue 
explants of human uterine myoma, mostly on the apo-
ptosis process. 
 
Examination of the influence of oxygen concentra-
tion  
Another important parameter in cultivating myoma tis-
sue could be the oxygen concentration in the incubator 
during culture, thus we compared two different concen-
trations in this study. We cultured tissue explants of 
uterine myoma in an incubator gassed either with stan-
dard normoxic gas (20% oxygen, 5% carbon dioxide, 
75% nitrogen) or with a special hypoxic gas (2% oxy-
gen, 5% carbon dioxide, 93% nitrogen). Culturing was 
done for one to six days since it has been suggested that 
the oxygen effect only occurs after a certain time of cul-
turing by increasing the life-span [25]. 
Culturing uterine myoma tissue explants under hypoxic 
conditions showed neither a higher proliferation index 
(Figure 5a) nor less apoptotic cells (Figure 5b), and thus 
no clear advantage over normoxic culture. Analyses of 
mRNA levels and contents of the hormone receptor pro-
teins ER and PR in the tissues using immunohistochem-
istry analysis showed no advantage at any point of time 
tested for the culture of uterine myoma under hypoxic 
conditions compared with those cultured under nor-
moxic conditions (data not shown). Based on these re-
sults, myoma tissues were cultured under normoxic 
conditions in all further tests. 
 
Hormone receptor content in relation to culture du-
ration 
Because of the known rapid loss of hormone receptor 
protein in cultured myoma tissue, we tested the content 
of ER and PR in tissue cultured for 24, 48, and 72 hours 
as well as in native myoma using IHC (Figure 6). A de-
crease was already seen after 24 hours of culture, but 
these differences were not significant, neither with re-
gard to ER (Figure 6a) nor to PR (Figure 6b). The first 
significant lower content of ER was found when tissue 
was cultured for 72 hours. PR content was only mini-
maly lower at 48 hours than at 24 hours, but not signifi-
cantly different to native tissue. 
 
 
DISCUSSION 
 
Uterine leiomyomas are the most common benign tu-
mours in women. Although they are the reason for nu-
merous hysterectomies each year [26], the pathogenesis 
of leiomyomas is generally unknown, mainly due to the 
lack of a viable cell culture model. Uterine leiomyomas 
usually do not occur in typical laboratory animals like 
mouse or rat, and human systems are only available as 
primary cultures with all the problems already de-
scribed. Even if cell based studies currently play an im-
portant part in myoma research, results should be re-
viewed critically prior to adopting for in vivo situations 
and/or for therapeutic considerations. Short-time cul-
turing of tissue explants of leiomyomas provides an 
economical and effective alternative to cell culture and 
ethical controversy regarding animal and xenograft mo-
dels. The problem is that culturing whole tissue slices is 
in general a very difficult method, last but not least be-
cause of their complex structures and all the different 
cell types with their special needs for culture conditions, 
which must be provided to keep original biological 
characteristics of the original tissue as long as possible. 
In particular, culturing uterine myoma tissue turned out 
to be a very special challenge not only because of its 
propensity to change the phenotype e.g. by loosing the 
hormone receptors in culture, but also because of its 
high morphological heterogeneity between different pa-
tients and even between different myomas of the same 
patient [27]. The size of the myoma [28] or other para-
meters not identified yet could be responsible for this. 
To establish tissue culturing as a dependable method 
even for sensitive myoma explants we here systemat-
ically optimised culturing conditions, and thus ensured 
that as much as possible of natural molecular biology in 
conjunction with characteristic qualities will be main-
tained during culturing time. As central parameters for 
culturing we tested different concentrations of oxygen, 
different media, sera, and supplements like hormones 
and EGF as important growth factors in uterine myoma 
pathogenesis. As a basic step toward finding the best 
way of culturing uterine myoma, we also tested differ-
ent culture systems. With regard to cost and suitability, 
we found the best to be 6-well plates with a metal grid 
to hold tissue pieces, which were more or less equal to 
the much more expensive LumoxTM system. We also 
compared uncropped myoma with myoma cut by a vi-
bratome. The cut explants were advantageous, and we 
carefully optimized the parameters for the vibratome 
cutting. In the beginning, there were some suggestions 
that embedding the tissue blocks in 4% agarose was 
useful to get equal slices of the very hard to cut myoma 
tissue. But after some tests it turned out that the agarose 
block increases the risk of damaging the tissue by sepa-
rating from the metal holder of the vibratome. In addi-
tion, it took valuable time to place the tissue in the aga-
rose. Since it is very important for cell health to be 
placed into culture media and incubator conditions as 
soon as possible, cutting in all further tests was done 
without agarose embedding.  
Myoma tissue often turned out to be a very sensitive 
material, e.g. to extract RNA from this tissue needed 
testing of several protocols before we discovered the ne-
cessity of keeping the material frozen until pulverisation 
was completed and trizol was added. Even then the pro-
cedure is very sensitive and difficult, and the yield is 
oftent limited. For this reason, the amount of material is 
an important factor, thus protocols extracting RNA 
from paraffin embedded blocks seems to be a good al-
ternative to the standard-trizol method. In this case, tis-
sue pieces can be used for both IHC and RNA analysis 
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at the same time. Pre-tests with two different protocols 
were promising. 
 
Suitable media for culturing myoma tissue 
An important factor for culturing cells or tissues is the 
choice of the media used. Besides standard media, there 
are numerous special media on the market. We com-
pared MCDB-131 (c.c.pro GMbH), “smooth muscle 
cell basal medium” (SMC, PromoCell), both special 
media for cultivation of smooth muscle cells, and stan-
dard medium D-MEM/F12 (InvitrogenTM). All media 
were without phenol red because this may affect growth 
of ER-dependent tissues [24]. SMC showed the worst 
results in all parameters tested. Differences between D-
MEM/F12 and MCDB-131 were only small. Because of 
the much lower price per bottle, D-MEM/F12 was cho-
sen as standard for culturing our myoma tissue explants.  
 
Optimal serum for culturing myoma tissue 
Similar to the media, the choice of serum as well as its 
concentration could strongly affect culture quality. 
Portier et al. showed medium with 2% horse serum or 
Ultroser®-G to cause muscular differentiation in myo-
blasts, whereas 10% fetal calf serum does not support 
differentiation [29]. Using media without any serum 
could be advantageous for the density of PR [30].  
Myoma tissues were cultured in different concentrations 
in fetal calf serum (FCS), horse serum (HS), Ultroser®-
G (CytoGen), and without any serum or serum replace-
ment. Differences were mainly seen in apoptosis, but 
even here they were not significant. It seems that horse 
serum at a final concentration of 1% is advantageous for 
culturing uterine myoma tissue. Lower concentrations 
of serum generally seem to have an advantage com-
pared to higher concentrations and also to culturing 
myoma without any serum supplement. Ultroser®-G 
showed no clear advantage compared to the other sub-
stances tested. Due to the expense, it was not used after 
the pre-tests. All together horse serum at a final concen-
tration of 1% was chosen because of its apoptosis index 
and its high relevance for culturing myoma tissues.  
 
Addition of hormones to the medium 
Myomas are hormone dependent tumours. Estrogens in-
crease the growth rate, progesterone has both increasing 
and decreasing effects [27]. In this study, we tested the 
influence of these hormones on cultured slices of myo-
ma tissue. Different tests with explants cultured in me-
dia without any hormone addition, in media with estra-
dion (E2) and/or progesterone (P) in different concen-
trations showed that an addition of estradiol at a final 
concentration of 10-8 M seemed to be advantageous 
over all other approaches. This fits with the double-
edged effect of progesterone shown in recent myoma re-
search [31].  
 
Addition of EGF to the medium 
Growth factors seem to have an important influence on 
the growth of myoma [27]. One of them, EGF [32], is 
known to increase proliferation and inhibit apoptosis. 
We tested EGF in different amounts as a supplement to 
the medium for culturing uterine myoma. At a lower 
apoptotic index, when EGF is added at a concentration 
of 10-7 M, it seems that EGF has a positive influence on 
cultured tissue explants of human uterine myoma, espe-
cially on apoptosis of the cells in a light dose dependent 
manner. This corresponds with the study of Maruo et 
al., where they found EGF to be advantageous for myo-
ma cell growing in culture because of the inhibition of 
apoptosis [33]. Estradiol, which inhibits the expression 
of Bcl-2, is also responsible for decreasing apoptosis 
[34], but addition of this hormone was similar in all me-
dia for testing EGF effects and thus most likely not re-
sponsible for the differences found here. We could not 
confirm the positive effect of EGF on the proliferation 
rate of cultured human myoma cells [33] in our myoma 
tissue cultures. Proliferation was very low without sig-
nificant differences in all tests.  
It must also be kept in mind that myoma express EGF 
and EGF-R themselves, and that estradiol and proges-
terone increase these proteins [33,34]. Thus different 
myoma cells especially from different patients could 
have different endogenous EGF rates. But even if this 
effect has no influence on the results because of the pre-
cise and careful cutting and culturing treatment to guar-
antee equal conditions and because only samples from 
the same myoma source were compared, it cannot be 
absolutely excluded that growth factors are not excreted 
uniformly in the same tumour and thus may have an in-
fluence on our results.  
 
Examination of the influence of oxygen concentra-
tion  
A very important question every scientist working with 
cultured cells or tissues has to ask regards the need and 
availability of oxygen for the cells. Normally, cell and 
tissue cultures in liquid media could be regarded as hy-
poxic, and it seems that only sufficient oxygen can keep 
the typical differentiation status of tissues [23]. Thus air 
exposure (AE) will be applied to many cell types, and 
Toda et al. found that cells in culture without AE turned 
necrotic and died much earlier [23]. But it is question-
able whether this is also valid for uterine myoma. The 
uterus is a tissue with a comparably low need for oxy-
gen, and leiomyomas are strongly hypoxic [35]. Aside 
from this, it was found that in some stem cell types 
hypoxia has the opposite effect. This means that it in-
creases the growth [36,37]. In addition, hypoxia is a 
known key factor for the physiology of malignant 
growth and regulates several important genes in this 
process [38]. The physiological oxygen concentration of 
mesenchymal stem cells (MSC) is with 1 to 7% [39], 
much lower than in a normal cell incubator with about 
20%, which could stand for oxygenic stress for the 
cells. Thus, an increasing number of scientists cultivate 
their MSC under hypoxic conditions, which is advanta-
geous mainly for long term culture [25,37,38]. Thus, the 
main effect seems to be not cell growth but expanded 
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life-span [25]. Cells with stem cell type characteristics 
found in the myometrium [40] proliferated in vitro only 
under reduced oxygen concentration of 2%. Therefore, 
it was worth testing the influence of lower oxygen con-
centration on the culture of myoma tissue explants. We 
compared hypoxic (2% oxygen) and normoxic (20% 
oxygen) incubator conditions in a long term culture test. 
However, the lower oxygen concentration showed no 
advantage for the cultured tissue explants, not even in 
long term culture of 144 hours. 
 
Hormone receptor content in relation to culture du-
ration 
As mentioned before, fast dedifferentiation of myoma 
cells in culture - especially the loss of hormone recep-
tors - is a main problem in studying these tissues [14, 
18,19]. After optimizing different parameters, we tested 
for the presence of hormone receptor proteins ER and 
PR in uterine myoma tissue cultured for 24, 48, and 72 
hours and compared these data to native tissue. As ex-
pected, the amount of both receptors was lower in cul-
tured pieces even after 24 hours compared to the con-
tent in native tissue. The first significant differences 
were found at 48 hours for PR and 72 hours for ER. 
Since there was only a minor difference of PR content 
between 24 and 48 hours and the clear decrease at 72 
hours, culturing myoma for less than 48 hours using the 
culture conditions described here seems to be optimal 
for studying these tissues. This provides a satisfactory 
quality with regard to the protein status of ER and PR, 
very important parameters regarding the characteristics 
of this tissue. However, our data showed a visible, al-
though not significant, decrease of the hormone recep-
tors even after 24 hours of culturing, which might be the 
reason for the absent or rather low influence of addi-
tional hormone supplements in the medium regarding 
apoptosis, proliferation, and hormone receptor protein 
status (see above).  
Taken together, the optimisation of the parameters 
tested for cultivating uterine myoma presented here pro-
mote culturing of these tissues as a promising alterna-
tive to the clearly more limited cell culturing and ethi-
cally controversial animal and xenograft approaches. 
This model, based on a much more natural biology than 
all others, has a wide spectrum for use, and results have 
a much higher probability to be transferable to human 
patients. This is necessary to be relevant for the allover 
aim of all myoma research: To find new therapeutic 
ways by enriching knowledge of this disease affecting 
so many women with pain, hyperhaemorrhage, and un-
wanted infertility. The protocol presented here for the 
culture of myoma tissue is a solid basis for using this 
approach for studying myoma tissue. However, it must 
be kept in mind that this also includes exploring the 
current problem of the immense heterogeneity of this 
tissue. Even myoma from the same patient can have ve-
ry different proliferation rates, apparently independent 
of the tumour size [3]. This makes optimisation of cul-
ture conditions for these tissues extremely difficult. In 
the end, it is necessary to have a protocol which best 
suits all not only a special type of myoma, and this can 
only achieved as a compromise. To reach this goal, as 
many different myoma as possible were analysed and 
compared to find common denominators for culture 
conditions in the study presented here. One of the prin-
cipal factors besides media, supplements, and incubator 
conditions and seems to be the minimisation of the time 
between extraction of the tissue from the patient and the 
time when this tissue is fed with medium under incuba-
tor conditions. In this very stressful space of time, cells 
are at a very high risk to start apoptotic processes, to 
loose their important biological characteristics like hor-
mone receptors, or at the very least to lose their capabil-
ity for mitotic activity.  
Because of the high heterogeneity even this protocol 
presented here and very carefully optimised must be re-
assessed from time to time with other and more myoma 
sources. Nevertheless, for now it is a useful tool and a 
good alternative to all other models. Our next focus will 
be the use of this model to examine the effects of 
known and potential therapeutic substances (e.g. anti-
progestins) on the cultured tissues and on the presence 
and influence of immune competent cells in the process 
of tumour formation to find new targets for medical 
treatment. 
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